258 related articles for article (PubMed ID: 16647144)
1. Immunomodulation of TGF-beta 1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: implications for antifibrotic therapy.
Andreetta F; Bernasconi P; Baggi F; Ferro P; Oliva L; Arnoldi E; Cornelio F; Mantegazza R; Confalonieri P
J Neuroimmunol; 2006 Jun; 175(1-2):77-86. PubMed ID: 16647144
[TBL] [Abstract][Full Text] [Related]
2. Localization and early time course of TGF-beta 1 mRNA expression in dystrophic muscle.
Gosselin LE; Williams JE; Deering M; Brazeau D; Koury S; Martinez DA
Muscle Nerve; 2004 Nov; 30(5):645-53. PubMed ID: 15389721
[TBL] [Abstract][Full Text] [Related]
3. T and B lymphocyte depletion has a marked effect on the fibrosis of dystrophic skeletal muscles in the scid/mdx mouse.
Farini A; Meregalli M; Belicchi M; Battistelli M; Parolini D; D'Antona G; Gavina M; Ottoboni L; Constantin G; Bottinelli R; Torrente Y
J Pathol; 2007 Oct; 213(2):229-38. PubMed ID: 17668421
[TBL] [Abstract][Full Text] [Related]
4. Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse.
Gibertini S; Zanotti S; Savadori P; Curcio M; Saredi S; Salerno F; Andreetta F; Bernasconi P; Mantegazza R; Mora M
Cell Tissue Res; 2014 May; 356(2):427-43. PubMed ID: 24723230
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline fails to attenuate fibrosis in dystrophic (mdx) diaphragm muscle.
Gosselin LE; Williams JE
Muscle Nerve; 2006 Jun; 33(6):820-3. PubMed ID: 16502423
[TBL] [Abstract][Full Text] [Related]
6. Temporal and spatial mRNA expression patterns of TGF-beta1, 2, 3 and TbetaRI, II, III in skeletal muscles of mdx mice.
Zhou L; Porter JD; Cheng G; Gong B; Hatala DA; Merriam AP; Zhou X; Rafael JA; Kaminski HJ
Neuromuscul Disord; 2006 Jan; 16(1):32-8. PubMed ID: 16373085
[TBL] [Abstract][Full Text] [Related]
7. Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-β1 blocker.
Taniguti AP; Pertille A; Matsumura CY; Santo Neto H; Marques MJ
Muscle Nerve; 2011 Jan; 43(1):82-7. PubMed ID: 21108244
[TBL] [Abstract][Full Text] [Related]
8. Effects of T-lymphocyte depletion on muscle fibrosis in the mdx mouse.
Morrison J; Palmer DB; Cobbold S; Partridge T; Bou-Gharios G
Am J Pathol; 2005 Jun; 166(6):1701-10. PubMed ID: 15920155
[TBL] [Abstract][Full Text] [Related]
9. Mdx respiratory impairment following fibrosis of the diaphragm.
Ishizaki M; Suga T; Kimura E; Shiota T; Kawano R; Uchida Y; Uchino K; Yamashita S; Maeda Y; Uchino M
Neuromuscul Disord; 2008 Apr; 18(4):342-8. PubMed ID: 18358722
[TBL] [Abstract][Full Text] [Related]
10. Long-term administration of pirfenidone improves cardiac function in mdx mice.
Van Erp C; Irwin NG; Hoey AJ
Muscle Nerve; 2006 Sep; 34(3):327-34. PubMed ID: 16770778
[TBL] [Abstract][Full Text] [Related]
11. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy.
Stedman HH; Sweeney HL; Shrager JB; Maguire HC; Panettieri RA; Petrof B; Narusawa M; Leferovich JM; Sladky JT; Kelly AM
Nature; 1991 Aug; 352(6335):536-9. PubMed ID: 1865908
[TBL] [Abstract][Full Text] [Related]
12. Reducing CTGF/CCN2 slows down mdx muscle dystrophy and improves cell therapy.
Morales MG; Gutierrez J; Cabello-Verrugio C; Cabrera D; Lipson KE; Goldschmeding R; Brandan E
Hum Mol Genet; 2013 Dec; 22(24):4938-51. PubMed ID: 23904456
[TBL] [Abstract][Full Text] [Related]
13. [Dystrophin expression and pathology of diaphragm muscles of mdx mice after xenogenic bone marrow stem cell transplantation].
Zhang YN; Zhang C; Yu MJ; Wang SH; Li MS; Huang H; Xiong F; Feng SW; Liu TY; Lu XL
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):53-8. PubMed ID: 16495176
[TBL] [Abstract][Full Text] [Related]
14. A comparison of factors associated with collagen metabolism in different skeletal muscles from dystrophic (mdx) mice: impact of pirfenidone.
Gosselin LE; Williams JE; Personius K; Farkas GA
Muscle Nerve; 2007 Feb; 35(2):208-16. PubMed ID: 17058274
[TBL] [Abstract][Full Text] [Related]
15. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
16. Changes in calsequestrin, TNF-α, TGF-β and MyoD levels during the progression of skeletal muscle dystrophy in mdx mice: a comparative analysis of the quadriceps, diaphragm and intrinsic laryngeal muscles.
Barros Maranhão J; de Oliveira Moreira D; Maurício AF; de Carvalho SC; Ferretti R; Pereira JA; Santo Neto H; Marques MJ
Int J Exp Pathol; 2015 Oct; 96(5):285-93. PubMed ID: 26515458
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).
Morales MG; Cabrera D; Céspedes C; Vio CP; Vazquez Y; Brandan E; Cabello-Verrugio C
Cell Tissue Res; 2013 Jul; 353(1):173-87. PubMed ID: 23673415
[TBL] [Abstract][Full Text] [Related]
18. Timeline of cardiac dystrophy in 3-18-month-old MDX mice.
Van Erp C; Loch D; Laws N; Trebbin A; Hoey AJ
Muscle Nerve; 2010 Oct; 42(4):504-13. PubMed ID: 20589894
[TBL] [Abstract][Full Text] [Related]
19. First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant.
Burdi R; Didonna MP; Pignol B; Nico B; Mangieri D; Rolland JF; Camerino C; Zallone A; Ferro P; Andreetta F; Confalonieri P; De Luca A
Neuromuscul Disord; 2006 Apr; 16(4):237-48. PubMed ID: 16542837
[TBL] [Abstract][Full Text] [Related]
20. The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.
Bellissimo CA; Gandhi S; Castellani LN; Murugathasan M; Delfinis LJ; Thuhan A; Garibotti MC; Seo Y; Rebalka IA; Hsu HH; Sweeney G; Hawke TJ; Abdul-Sater AA; Perry CGR
Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1011-C1026. PubMed ID: 38145301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]